SARS-CoV-2 Spike receptor binding domain RBD. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant.
SARS-CoV-2 Spike receptor binding domain RBD. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant.
SARS-CoV-2 Spike receptor binding domain RBD. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells, purified from culture supernatant and conjugated to biotin.
SARS-CoV-2 Spike receptor binding domain RBD. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant.